The assay input requirement ranges from 25 ng to 2 µg DNase-treated total RNA. For RNA samples with a concentration of <6.25 ng/µL, we recommend using the DNAclear Purification Kit (Cat. No. AM1756) to concentrate the sample after performing reverse transcription. We recommend using ≥ 50 ng DNase-treated total RNA depending on sample type, ranging from 50-2,000 ng (see "Saturation analysis of peripheral blood leukocytes (PBL) - Oncomine BCR IGH Assay" on page 159 and "Saturation analysis of tissue - Oncomine BCR IGH Assay" on page 161 of the user guide (https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0017438_OncomineTCRBetaAssay_UG.pdf).
When using degraded samples (FFPE) or samples with unknown B or T-cell content, perform sample qualification and quantitation to determine the minimum sample input that is required. For more information, see Appendix B, "Sample qualification and quantitation" on page 130 of the user guide.
Find additional tips, troubleshooting help, and resources within our
Next-Generation Sequencing Support Center.